Edition:
United States

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

19.17USD
15 Dec 2017
Change (% chg)

$0.12 (+0.63%)
Prev Close
$19.05
Open
$19.00
Day's High
$19.62
Day's Low
$18.68
Volume
806,711
Avg. Vol
73,521
52-wk High
$24.85
52-wk Low
$11.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
FY 2016 Dec '16 2.34 1.395
Sep '16 1.55 -0.369
Jun '16 0.80 -0.432
Mar '16 0.48 -0.212
FY 2015 Dec '15
Sep '15 0.00 -0.160
Jun '15 0.00 -0.092
Mar '15 0.00 -0.081
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 3.46 5.40 0.50 4.00
Quarter Ending Mar-18 2 2.45 4.40 0.50 4.00
Year Ending Dec-17 4 11.60 12.91 9.20 6.56
Year Ending Dec-18 4 13.05 24.00 2.00 7.46
Earnings (per share)
Quarter Ending Dec-17 5 -0.70 -0.66 -0.77 -0.49
Quarter Ending Mar-18 3 -0.68 -0.67 -0.69 -0.48
Year Ending Dec-17 5 -2.43 -2.37 -2.49 -2.18
Year Ending Dec-18 5 -3.01 -2.78 -3.15 -2.79
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) 71.38 122.78 5.95
Price to Book (MRQ) 4.33 23.45 5.68
Price to Tangible Book (MRQ) 4.40 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 42.92 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 54.10 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 259.18 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -66.87 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 75.70 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 21.34 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -6.22 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -801.49 -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -825.44 -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -450.89 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -466.58 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 118,452 22,314,532 851,801,741
Net Income/Employee (TTM) -552,677 -1,997,855 99,542,701
Receivable Turnover (TTM) 4.15 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.04 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -18.32 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -21.83 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -88.25 -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 1,990.69 -- --
EPS (TTM) % -194.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.92%
# of Holders: 69
Total Shares Held: 17,603,635
3 Mo. Net Change: 315,012
# New Positions: 30
# Closed Positions: 4
# Increased Positions: 43
# Reduced Positions: 9
# Net Buyers: 34
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.